Revisiting the Nanoflow Cytometric Quantification of Extracellular Vesicles Under the Framework of ICH Q14 Guidelines
Journal of Extracellular Biology · 2025-05 · 4 (5)
DOI: 10.1002/jex2.70050 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Extracellular Biology, online erschienen am 08.05.2025. Verfasst von Ganghui Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: China Pharmaceutical University Nanjing China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Nanoflow cytometry (nanoFCM) is an increasingly important analytical procedure in every aspect of extracellular vesicle (EV) research, particularly in the development of EV‐based therapeutics. The main objective of this study was to evaluate and optimise the key determinant factors of nanoFCM in the quantification analysis of EVs to ensure its consistency and reliability in the development of EV therapeutic drugs, thereby serving as a potential quality control measure. Our investigation followed the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q14 guideline. We revisited the day‐to‐day practice of nanoFCM measurement for HEK293 cell‐derived and milk‐derived EVs (mEVs), focusing on optimising particle quantification and identifying risk factors. Initial evaluation of the procedure revealed a considerable lack of consistency and reliability, which was then subjected to extensive optimisation. The key outcomes of this study include: (1) an optimised analytic procedure incorporating Tween‐20, which significantly enhanced the precision and accuracy of the nanoFCM measurement and expanded the reportable range; (2) an analytical target profile (ATP) which provides a preliminary standard for future validation of nanoFCM procedures. Overall, this study serves as a foundation for future efforts towards the standardisation of analytical procedures for EV therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- China Pharmaceutical University Nanjing China.
- Department of Ultrasound Beijing Chao-Yang Hospital Capital Medical University Beijing China.
- PanExo Biotech Co Ltd. Beijing China.
- National Institutes for Food and Drug Control Beijing China.
- State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing) Beijing Institute of Lifeomics Beijing China.
- Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation Guangxi China.
ORCID-Profile: Ganghui Li
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Li, G., Cai, Q., Dong, Y., Li, X., Qin, X., Xue, M., Song, H., & Wang, Y. (2025). Revisiting the Nanoflow Cytometric Quantification of Extracellular Vesicles Under the Framework of ICH Q14 Guidelines. Journal of Extracellular Biology, 4(5). https://doi.org/10.1002/jex2.70050
Vancouver
Li G, Cai Q, Dong Y, Li X, Qin X, Xue M, et al. Revisiting the Nanoflow Cytometric Quantification of Extracellular Vesicles Under the Framework of ICH Q14 Guidelines. Journal of Extracellular Biology. 2025;4(5). doi:10.1002/jex2.70050
BibTeX
@article{Li2025,
author = {Li, Ganghui and Cai, Qizhe and Dong, Yanan and Li, Xiang and Qin, Xi and Xue, Miaomiao and Song, Haifeng and Wang, Yi},
title = {Revisiting the Nanoflow Cytometric Quantification of Extracellular Vesicles Under the Framework of ICH Q14 Guidelines},
journal = {Journal of Extracellular Biology},
year = {2025},
volume = {4},
number = {5},
doi = {10.1002/jex2.70050}
}
EUVIMED